Previous 10 | Next 10 |
The Institute for Clinical and Economic Review (ICER), a Boston-based nonpartisan nonprofit with no policy-making role, has emerged as a major influencer on pricing by drugmakers. More news on: Sanofi, Regeneron Pharmaceuticals, Inc., Amgen Inc., Healthcare stocks news, News on ETFs, ...
Presidential candidate Senator Elizabeth Warren (D-MA) has finally released the projected cost of her plan for universal healthcare, called "Medicare for All," a whopping $20.5T over 10 years. More news on: Tekla World Healthcare Fund, BlackRock Health Sciences Trust, The Gabelli Healthc...
In a statement , the FDA says chronic shortages of certain medicines in the U.S. have not produced the expected responses from drugmakers that traditional economics predict, specifically, increasing prices to reflect a supply/demand imbalance aimed at achieving profitable production to sati...
Introduction Given the ample historical evidence, this seems to be a classic scenario surrounding a yield curve inversion before a recession. None of the leading indicators are clearly signaling that this time could be different. - Who Wants To Bet Against The Yield Curve: Is This ...
In the face of criticism from her Presidential rivals, Senator Elizabeth Warren (D-MA) says she will "soon release" her plan to pay for "Medicare for All," her proposal for universal healthcare in the U.S. She commented on the issue during a campaign stop in Indianola, IA. More news on: ...
On a strict party line basis, the U.S. House of Representatives' Education and Labor Committee voted 27-21 backing Speaker Nancy Pelosi's drug pricing bill (H.R. 3). All 27 Dems voted in favor and all 21 GOP members voted against. More news on: Pfizer Inc., Merck & Co., Inc., Bristol...
A preliminary analysis from the nonpartisan Congressional Budget Office (CBO) found that House Speaker Nancy Pelosi's (D-CA 12th District) bill to lower drug prices would save Medicare $345B between 2023 and 2029 by allowing the Secretary of Health and Human Services to negotiated lower pr...
According to a new report from the nonprofit Institute for Clinical and Economic Review (ICER), AbbVie ( ABBV -0.6% ) and Roche ( OTCQX:RHHBY -1.6% ) were number one and two, respectively, in terms of the impact of their price increases on U.S. drug spending. More news on: AbbVie Inc...
Note: This report was released to members one month ago. Chemist's Closed-End Fund Report Quantitative screens help to rapidly narrow down attractive candidates from the database of 500-plus closed-end funds (CEFs) for further due diligence and investigation. Previous editions of the Rep...
There are an increasing number of fears hitting the minds of investors today. As I have discussed in past articles (such as this one ), there are a growing number of signs that the American economy is beginning to slow down. In addition to this, we have concerns about the ongoing trade war be...
News, Short Squeeze, Breakout and More Instantly...
Blackrock Health Sciences Trust Company Name:
BME Stock Symbol:
NYSE Market:
Blackrock Health Sciences Trust Website:
2024-07-10 03:12:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
The BlackRock closed-end funds (the “Funds”) listed below announced today the results of the Quarterly Measurement Period (as defined below) under their previously announced discount management programs (the “Programs”). Funds with a Trigger Event (as defined below) at...
2024-06-20 05:18:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...